What Trialo does
Trialo is an AI clinical evidence platform that extracts and analyzes efficacy endpoints from regulatory submissions, scientific literature and public documents to give quick insight into clinical trial data. It is aimed at pharmaceutical and biotech companies, investment firms, contract research organizations and health technology assessment teams. Named features include DiseaseXplorer, an indication-centric dashboard for comparing endpoints and outcomes, drug efficacy comparison, drug and trial analytics, structured efficacy data, source document verification and an AI research assistant. Pricing has three tiers: a Basic plan at $0.00 a month limited to one disease and one drug with US data, a Pro plan at $200.00 a month covering all indications, and an enterprise Ultimate plan with a waitlist.
How Trialo compares with its closest alternatives
2 of the 5 closest alternatives have a free plan, as Trialo does. Only Yila AI lists a starting price, $16 a month. 2 of the 5 offer an API. Trialo offers a web app. Of the alternatives, all 5 offer a web app. Trialo was founded in 2025; the alternatives were founded between 2019 and 2025, 2 of them earlier. Trialo is based in Singapore; all the 3 alternatives with a known headquarters are in Singapore too.